StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)

Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%

Dr Reddys Laboratories operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was ₹56.76B, up 22.2% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is ₹58.88B in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026₹56.76B+22.2%
FY2025Mar 31, 2025₹46.43B+2.2%
FY2024Mar 31, 2024₹45.43B-22.8%
FY2023Mar 31, 2023₹58.88B+109.5%
FY2022Mar 31, 2022₹28.11B-21.3%
FY2021Mar 31, 2021₹35.70B+19.6%
FY2020Mar 31, 2020₹29.84B+4.0%
FY2019Mar 31, 2019₹28.70B+59.2%
FY2018Mar 31, 2018₹18.03B-16.2%
FY2017Mar 31, 2017₹21.51B-47.8%
FY2016Mar 31, 2016₹41.25B–

More Dr Reddys Laboratories figures

See a number that looks wrong?